ArticleVeterinary research2025
Seroprevalence and genetic diversity of feline immunodeficiency virus in outdoor cats in France.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feline immunodeficiency virus (FIV) is a retrovirus that causes lifelong infections in cats and may lead to immune dysfunction. Despite its importance for feline health, there is limited FIV data from France. This study investigated samples collected from stray and owned cats with outdoor access across France between December 2023 and January 2025 to estimate FIV seroprevalence, identify seropositivity predictors and analyse the genetic diversity of circulating strains. Serological screening was performed using a commercial ELISA. Polymerase chain reaction (PCR) was conducted on ELISA-positive sera, with selected samples analysed by Sanger sequencing for phylogenetic inference. One sample underwent metagenomic shotgun sequencing using Oxford Nanopore technology. The national seroprevalence, estimated using a Bayesian hierarchical model, was 16% (95% credible interval: 8.4-20%) overall, then 31% (21-42%) among intact male cats, 18% (CrI: 10.6-25.2%) among neutered male cats and 8.4% (CrI: 1.8-14%) among female cats. Outdoor exposure, sex and neuter status were strong predictors of seropositivity. Among strays, predicted probability of seropositivity exceeded 50% by 5 years of age. All sequenced viruses were classified as subtype A. However, the phylogenetic analysis revealed notable genetic variability, indicating at least two independent introductions of FIV into France. While related to other European strains, several isolates appeared to share distinct ancestral lineages. The metagenomic dataset yielded approximately 100,000 FIV reads among 2 million total reads, enabling full genome recovery. These findings highlight the ongoing circulation of FIV in France and provide valuable data for veterinary practitioners and future surveillance efforts in Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.